Last reviewed · How we verify
NCT04169802
Study Evaluating Retinal Health Monitoring System Visual Acuity Module.
trial testing Retinal Health Monitoring System Visual Acuity Module in Age Related Macular Degeneration in 25 participants. Completed in 15 April 2020.
15 April 2020
Quick facts
| Lead sponsor | Kubota Vision Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 20 November 2019 |
| Primary completion | 15 April 2020 |
| Estimated completion | 15 April 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Retinal Health Monitoring System Visual Acuity Module
- Sloan letter, logarithmic near visual acuity chart (Reference Chart)
Conditions studied
- Age Related Macular Degeneration — all drugs for Age Related Macular Degeneration →
Sponsor
Kubota Vision Inc. — full company profile →
Who can join
50 and older, any sex, with Age Related Macular Degeneration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assess the performance and usability of the RHMS Visual Acuity Module.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04169802
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Age Related Macular Degeneration
Currently open trials in the same condition.
- NCT07461441 — Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal · Phase 3 · recruiting
- NCT07235527 — Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degener · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT03102138 — Retinal Pigment Epithelium Safety Study for Patients in B4711001 · active not recruiting
- NCT05698316 — A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Predicti · active not recruiting
Other Kubota Vision Inc. trials
Trials by the same sponsor.
- NCT06085430 — Kubota Glass Parameter Refinement Study · NA · completed
- NCT04499703 — Evaluation of the Retinal Health Monitoring System Thickness Module · completed
- NCT04415684 — Projected Peripheral Defocus Using a Wearable Device · NA · completed
- NCT04388020 — Effects of Projected Peripheral Defocus on Ocular Biometrics · NA · completed
- NCT03772665 — Safety and Efficacy of Emixustat in Stargardt Disease · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04169802 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kubota Vision Inc.
- Last refreshed: 21 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169802.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing